These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7900709)

  • 1. A phase II trial of edatrexate in previously treated ovarian cancer. A Gynecologic Oncology Group study.
    Broun ER; Iseminger KA; Bookman M
    Am J Clin Oncol; 1995 Apr; 18(2):164-6. PubMed ID: 7900709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.
    Broun ER; Iseminger KA; Rose PG; Lentz SL; Malfetano JH; Lincoln S; Mannel R
    Am J Clin Oncol; 1997 Feb; 20(1):78-80. PubMed ID: 9020294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.
    Kuebler JP; Benedetti J; Schuller DE; Ensley J; Grunberg SM; Muirhead MJ; Richert-Boe KE; Marshall ME
    Invest New Drugs; 1994; 12(4):341-4. PubMed ID: 7775138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).
    Meyers FJ; Lew D; Lara PN; Williamson S; Marshall E; Balcerzak SP; Rivkin SE; Samlowski W; Crawford ED
    Invest New Drugs; 1998-1999; 16(4):347-51. PubMed ID: 10426670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of edatrexate in advanced breast and other cancers.
    Kuriakose P; Gandara DR; Perez EA
    Cancer Invest; 2002; 20(4):473-9. PubMed ID: 12094542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of edatrexate in patients with metastatic colorectal cancer.
    Clamon GH; Riggs CE; Dreicer R; Hohl RJ
    Invest New Drugs; 1996; 13(4):359-61. PubMed ID: 8824357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group study.
    Manetta A; Blessing JA; Look KY
    Am J Clin Oncol; 1995 Apr; 18(2):156-7. PubMed ID: 7534978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
    D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD
    Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study.
    Dreicer R; Propert KJ; Kuzel T; Kirkwood JM; O'Dwyer PJ; Loehrer PJ
    Am J Clin Oncol; 1997 Jun; 20(3):251-3. PubMed ID: 9167747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.
    Casper ES; Christman KL; Schwartz GK; Johnson B; Brennan MF; Bertino JR
    Cancer; 1993 Aug; 72(3):766-70. PubMed ID: 8392904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
    Moore DF; Pazdur R; Abbruzzese JL; Ajani JA; Dubovsky DW; Wade JL; Belt RJ; Mangold C; Bready B; Winn RJ
    Ann Oncol; 1994 Mar; 5(3):286-7. PubMed ID: 8186177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer.
    Schornagel JH; van der Vegt S; Verweij J; de Graeff A; Dullemond-Westland A; van Deijk WA; ten Bokkel Huinink WW
    Ann Oncol; 1992 Jul; 3(7):549-52. PubMed ID: 1498076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.
    Pazdur R; Moore DF; Bready B; Giannone L; Maldonado A; Lin YG; Fueger RH; Winn RJ; Levin B
    Ann Oncol; 1994 Sep; 5(7):646-8. PubMed ID: 7527654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
    Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; de Graeff A; Clavel M
    J Clin Oncol; 1995 Jul; 13(7):1649-55. PubMed ID: 7602354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.
    Plaxe SC; Blessing JA; Bookman MA; Creasman WT
    Gynecol Oncol; 2002 Jan; 84(1):32-5. PubMed ID: 11748972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
    Casper ES; Schwartz GK; Johnson B; Kelsen DP
    Invest New Drugs; 1992 Nov; 10(4):313-6. PubMed ID: 1487406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    Look KY; Blessing JA; Adelson MD; Morris M; Bookman MA
    Am J Clin Oncol; 1996 Feb; 19(1):7-9. PubMed ID: 8554040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.
    Kindler HL; Belani CP; Herndon JE; Vogelzang NJ; Suzuki Y; Green MR
    Cancer; 1999 Nov; 86(10):1985-91. PubMed ID: 10570422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
    Krug LM; Ng KK; Kris MG; Miller VA; Tong W; Heelan RT; Leon L; Leung D; Kelly J; Grant SC; Sirotnak FM
    Clin Cancer Res; 2000 Sep; 6(9):3493-8. PubMed ID: 10999734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.